United States v. Lee

107 F.2d 522, 1939 U.S. App. LEXIS 2783
CourtCourt of Appeals for the Seventh Circuit
DecidedNovember 22, 1939
Docket6867
StatusPublished
Cited by21 cases

This text of 107 F.2d 522 (United States v. Lee) is published on Counsel Stack Legal Research, covering Court of Appeals for the Seventh Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Lee, 107 F.2d 522, 1939 U.S. App. LEXIS 2783 (7th Cir. 1939).

Opinion

KERNER, Circuit judge.

The defendant, Royal Lee (trading as the Vitamin Products Company of Milwaukee, Wisconsin), appeals from a judgment which pronounced a sentence upon him after conviction by jury. In four counts, the indictment charged him with the interstate shipment of his product “Catalyn” on October 23 and November 2 of 1933, and with the misbranding of Catalyn, thereby violating Sections 2 and 8 of the Food and Drug Act of 1906, as amended. See 21 U.S.C.A. §§ 2, 9, 10; see also Secs. 1 and ,7.

Counts 1 and 3 of the indictment charged that certain representations, pertaining to the curative and therapeutic effect of Catalyn and printed on the bottle labels, wrappers and enclosures, were false and fraudulent. 21 U.S.C.A. § 10. In this regard, it was alleged that by these means defendant intended to deceive buyers and to create in their minds the impression that *524 Catalyn contained ingredients effective to cure, mitigate, or prevent over fifty enumerated ailments, e. g., dropsy, goiter, heart trouble, and stomach ulcers.

Counts 2 and 4 of the indictment charged that certain statements pertaining to the contents ■ or ingredients of Catalyn were false and misleading. 21 U.S.C.A. § 9. In this connection, it was alleged that the particular information on the bottle labels indicated falsely that Catalyn contained definite proportions of the various vitamins. On this appeal, the fact finding of interstate commerce, amply supported by the evidence, was not contested. 21 U.S, C.A. § 2. ; . . .

The defendant was tried before the jury and convicted on all four counts. The court imposed sentence and the defendant appealed therefrom. In his appeal, defendant urges consideration of the following assigned errors: (1) refusal to discharge defendant at the close of plaintiff’s case; (2) justice not done; (3) misconduct of trial judge; (4) improper admission and rejection of evidence; (S) improper assessment of costs; (6) refusal to grant bill of particulars; and (7) erroneous instructions. Our considerations follow.

Refusal to Discharge Defendant at close of Plaintiff’s Case. In order to consider the error here assigned, it is necessary to analyze the Government’s evidence in the light of the charge made in the indictment. In this case, defendant holds his Catalyn tablet out to the buying public as containing various vitamins and definite proportions thereof; he also states that Catalyn is effective for the treatment of certain enumerated diseases and ailments. On the other hand, the Government alleges in the indictment that Catalyn does not contain the named vitamins or definite proportions thereof, and that Catalyn’s therapeutic claims are exaggerated and intended to deceive the public. Has the Government proved its case?

Evidence adduced in the form of physical and documentary exhibits clearly show Lee’s representations concerning the contents and curative effect of Catalyn. The bottle label stated that the bottle “Contains Vitamins: A-B-C-D-E-F-& G; in such proportions as to most effectively restore normal metabolism where abnormality is present.” The blue circular accompanying the bottle of Catalyn tablets stated, in substance and among other things, that Catalyn was effective for the treatment of Pernicious Anemia, Dropsy, Goiter, Heart Trouble, Underweight, Pneumonia, Bright’s Disease, St. Vitus Dance in Children and Stomach Ulcers. Booklets advertising Catalyn revealed such statements as “Catalyn * ■ * * Recommended and Guaranteed for Goiter, Heart Trouble, * * * Insomnia, * * * Anemia, * * * Dropgy 4s 4s

The Government introduced evidence relating to the composition and constituent ingredients of Catalyn. The testimony in this regard disclosed that Catalyn did not contain vitamins A, C or D, and that it did contain l%o international units of vitamin B and vitamin G equal to Vi gram of dried yeast. Further testimony indicated that vitamin G is now known as vitamin B, and pointed out that the user would have to take 150 Catalyn tablets per day to meet the body’s daily minimum need therefor. - ■

It is obvious that this evidence refutes defendant’s representations that Catalyn consisted of vitamins A-B-C-D-E-F-G in “such proportions as to most effectively festore normal metabolism where abnormality is present.” .In addition, this evidence also militates against defendant’s assertions that Catalyn possessed therapeutic value, for Catalyn’s curative powers are necessarily based on the named vitamins.

The source of the evidence discussed above is the biological analysis of Catalyn conducted by the Vitamin Division of the United States Food and Drug Administration. This vitamin assay of Catalyn was made under the supervision of Nelson, a recognized authority on vitamins and vitamin standards. Nelson was aided by Irish (chemist), who directly determined the vitamin contents of Catalyn and who also made a chemical analysis in the case of vitamin C. This bio-assay analysis was supported by a qualitative examination by Yakowitz (analytic chemist), microscopic examination by Keenan (microanalyst), and a quantitative examination by Light-body (pharmacologist).

The bio-assay test used here, namely, the bio-logical method of measuring the vitamin contents of a given product by employing experimental animals (white rats and guinea pigs), is the test accepted and the method officially recognized by the consensus of expert opinion in the field of medicine, pharmacy, and nutrition. In this *525 case, the accuracy of the biological analysis and the evidence obtained therefrom stands uncontradicted and unquestioned.

In this connection, it is interesting to note that defendant’s witness Dr. Barrett, in discussing the bio-assay test, remarked that it is “the best way we now have” to determine the presence or absence of vitamins in a given product. Moreover, defendant’s witness Dr. Kanoky testified that “if I wanted to know how much vitamin there was in a Catalyn pill I would turn it over to a biologist” and that the “bio-assay method is the accepted method by the profession to determine the quantity of vitamins in a given product.”

The Government then adduced expert testimony relating to the therapeutic 'or curative value of Catalyn; In substance, the physicians called by the Government testified to and agreed on two propositions: (1) that assuming the accuracy of the vitamin analysis (and, as we have stated before, the accuracy thereof is not attacked), Catalyn lacks therapeutic merit; (2) that assuming Catalyn contained the represented vitamins, its curative value would nevertheless be confined to vitamin-deficiency cases, which excludes such diseases and ailments as measles, anemia, dropsy, goiter, valve leakage of the heart, pneumonia, Bright’s disease, St. Vitus Dance, leg ulcers, and stomach ulcers. ■ .

These physicians — Drs. Hart, Sevringhaus, Quick, Lettenberger, Brussock, and Goldwater — explicitly added that their testimonies expressed opinions that represent^ ed the consensus of reliable medical knowledge. To us it is significant that defendant’s expert witnesses did not controvert these expressions. Such an omission suggests to us that the opinions of defendant’s expert witnesses, as to whether the above enumerated maladies are vitamin-deficiency diseases, were personal ones and not in accord with the consensus of reliable medical knowledge.

Dr.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Howard M. Gering
716 F.2d 615 (Ninth Circuit, 1983)
Bailey v. Meister Brau, Inc.
378 F. Supp. 883 (N.D. Illinois, 1974)
United States v. James R. Hoffa and Calvin Kovens
497 F.2d 294 (Seventh Circuit, 1974)
Paul J. Richard v. United States
315 F.2d 331 (First Circuit, 1963)
The United States of America v. Nicholas A. Stirone
311 F.2d 277 (Third Circuit, 1963)
United States v. Bodine Produce Co.
206 F. Supp. 201 (D. Arizona, 1962)
United States v. Redfield
197 F. Supp. 559 (D. Nevada, 1961)
United States v. Caplan
123 F. Supp. 862 (W.D. Pennsylvania, 1954)
Mueller v. Powell
115 F. Supp. 744 (W.D. Missouri, 1953)
Butler v. United States
191 F.2d 433 (Fourth Circuit, 1951)
United States v. Stoehr
100 F. Supp. 143 (M.D. Pennsylvania, 1951)
Billman v. Kroger Co.
185 F.2d 120 (Seventh Circuit, 1950)
United States v. Amorosa
167 F.2d 596 (Third Circuit, 1948)
Griffin v. United States
164 F.2d 903 (D.C. Circuit, 1947)
United States v. Earnhardt
153 F.2d 472 (Seventh Circuit, 1946)
Steiner v. United States
134 F.2d 931 (Fifth Circuit, 1943)
Moore v. United States
132 F.2d 47 (Fifth Circuit, 1942)
United States v. 111/4 DOZEN PACKAGES, ETC.
40 F. Supp. 208 (W.D. New York, 1941)

Cite This Page — Counsel Stack

Bluebook (online)
107 F.2d 522, 1939 U.S. App. LEXIS 2783, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-lee-ca7-1939.